CenterWatch
  • Search Clinical Trials
  • Clinical Trial Listings
  • Volunteer
  • Learn About Clinical Trials

Gernoble, France

< 2 Miles
Filters

Type

Distance
Age
0
0
Gender
Trial Phase
Sponsor
  • Improved Robotic-Assisted Radical Prostatectomy for Locally Advanced Prostate Cancer: Bladder Suspension and Preliminary Outcomes

    Phase

    N/A

    Span

    157 weeks

    Sponsor

    First Affiliated Hospital of Fujian Medical University

    Fuzhou, Fujian

    Recruiting

  • IL-6: A Marker for AML Chemo Sensitivity

    In this prospective study, we will collect bone marrow supernatant samples from patients diagnosed with Acute Myeloid Leukemia (AML) to evaluate the levels of Interleukin-6 (IL-6). Our aim is to explore whether elevated IL-6 levels can serve as a predictive biomarker for poor treatment outcomes following standard chemotherapy regimens. The findings may help in stratifying patient risk and personalizing therapeutic approaches in AML treatment.

    Phase

    N/A

    Span

    92 weeks

    Sponsor

    Fujian Medical University Union Hospital

    Fuzhou, Fujian

    Recruiting

  • Research on the Development and Clinical Evaluation of Biomimetic Abutments

    The biomimetic healing abutments were placed during the second-stage surgery, and the biomimetic prosthetic abutments were used to complete the implant restoration. To assess soft tissues, digital models were collected in STL files at five time points: before the second-stage surgery, before the implant impression, immediately after restoration, six months after restoration, and 12 months after restoration. These models were analyzed using 3D software for model matching and measurement based on CBCT, focusing on the changes on soft tissue height, width, and volume. Hard tissue evaluation was conducted through periapical radiographs taken at three time points: immediately after restoration, six months after restoration, and 12 months after restoration. Additionally, general clinical conditions were assessed at the same three time points, evaluating parameters such as food impaction, plaque index, and gingival index.

    Phase

    N/A

    Span

    97 weeks

    Sponsor

    Stomatological Hospital Affiliated with Fujian Medical University

    Fuzhou, Fujian

    Recruiting

  • Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis

    Phase

    3

    Span

    102 weeks

    Sponsor

    Beijing InnoCare Pharma Tech Co., Ltd.

    Fuzhou, Fujian

    Recruiting

  • Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants with CHB with Low Viral Load

    Phase

    2

    Span

    52 weeks

    Sponsor

    Ausper Biopharma Co., Ltd.

    Fuzhou, Fujian

    Recruiting

  • Clinical Trial of TQB2825 Injection Combined Immunochemotherapy in Subjects With Diffuse Large B Cell Lymphoma

    Phase

    1/2

    Span

    89 weeks

    Sponsor

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

    Fuzhou, Fujian

    Recruiting

  • IBI3014 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

    Phase

    1/2

    Span

    115 weeks

    Sponsor

    Innovent Biologics (Suzhou) Co. Ltd.

    Fuzhou, Fujian

    Recruiting

  • A Prospective Multicenter Registry Study on BASIS Technique for Endovascular Therapy of Acute Large Vessel Occlusion Strokes Due to Intracranial Atherosclerotic Disease

    This project intends to set up a prospective multi-center single-arm study with no control group and no upper limit of cases. Using BASIS (Balloon AngioplaSty with the dIstal protection of Stent retriever) technique . - Balloon angioplasty under the protection of the remote thrombectomy stent for intravascular treatment, such as the BASIS technique for thrombectomy loss Failure, the surgeon can take different techniques for remedial treatment. 1. Construct the three-axis system and establish the path. The microcatheter passes 15mm through the distal end of the thrombus Above, after the thrombectomy stent covering the narrow segment was released, angiography was performed to observe the stenosis and distal thrombus. 2. Use the anchoring effect of the thrombectomy bracket to pull the microcatheter out of the body. 3. Send the guide wire along the thrombectomy stent to the balloon expansion catheter, and place the balloon in the narrow section. At this time, follow the blood The position of the plug relative to the stenosis determines whether to semi-retrieve the Syphonet® plug holder, fill the balloon for expansion, Balloon pressure relief. 4. Use the distal end of the thrombectomy stent to anchor and the support of the balloon dilating catheter to advance the thrombectomy catheter. Until the end of the thrombus suction catheter reaches the narrow site. 5. Remove the balloon to enlarge the suction cavity and remove the thrombus using SWIM technique. 6. The residual thrombus was cleaned up and the thrombectomy stent was released again. The thrombectomy stent was recovered after angiographic observation: assembled in vitro With the microcatheter, the thrombectomy stent was released again via the microcatheter. Angiography was performed to observe the treatment of thrombus and stenosis Avoid thrombus escape due to direct hand angiography, if there is still thrombus, continue mechanical thrombus removal until the thrombus is cleared After the microcatheter was recovered and the thrombectomy scaffold was withdrawn, the micro

    Phase

    N/A

    Span

    105 weeks

    Sponsor

    Fujian Medical University Union Hospital

    Fuzhou, Fujian

    Recruiting

  • A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma

    Phase

    3

    Span

    146 weeks

    Sponsor

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

    Fuzhou, Fujian

    Recruiting

  • Clinical Studies for the Treatment of Advanced Solid Tumors

    Phase

    1/2

    Span

    78 weeks

    Sponsor

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

    Fuzhou, Fujian

    Recruiting

1-10 of 546
CenterWatch

5000 Centregreen Way, Suite 200
Cary, NC, 27513, USA

Phone: 703.538.7600
Toll Free: 888.838.5578

  • Disclaimer
  • Privacy Policy
  • Term of Use
  • Do Not Sell My Personal Information